euro adhoc: Marseille-Kliniken AG / Annual Reports / 5% increase in sales during the fiscal year 2003/2004 to 200.1 million Fundings for the Rehabilitation division depress total result to DVFA (IAS) to 7.5 million (previous year: 8.5 million) 1.
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) increased sales in the fiscal year 2003/04 by 5% to 200,1 million (previous year: 191.1 million). The earnings to DVFA/SG ...